Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Dickens

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Pediatric Blood & Cancer|January 12, 2010
Comparing pediatric deaths with and without hospice supportDavid S Dickens
Journal of Palliative Medicine|July 15, 2009
Building competence in pediatric end-of-life careDavid S Dickens
Pediatric Blood & Cancer|April 25, 2017
Medication prior authorization in pediatric hematology and oncologyDavid S Dickens, Brad H Pollock
Pediatric Blood & Cancer|July 31, 2021
Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemiaTorin W Waters, David S Dickens
Psychology, Health & Medicine|November 3, 2021
Choice architecture for young adult blood donor recruitment - a feasibility studyJohn I Dickens, David S Dickens
Journal of Pediatric Hematology/Oncology|September 16, 2003
Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenograftsDavid S Dickens, Timothy P Cripe
Journal of Pediatric Hematology/Oncology|January 7, 2009
Therapeutic strategies for targeting mononuclear phagocytes in cancerDavid S Dickens, Paul T Jubinsky
Journal of Pediatric Hematology/Oncology|August 21, 2018
Barriers to Medication Access in Pediatric Oncology in the United StatesMichael J Kelly, Lillian Sung, David S Dickens
Journal of Pediatric Hematology/Oncology|September 19, 2008
New roles for mononuclear phagocytes in cancer biologyPaul T Jubinsky, David S Dickens, Mary K Short
JCO Oncology Practice|May 13, 2020
Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research ProgramsDavid S Dickens, Michael E Roth, Brad H Pollock, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|January 12, 2010
Comparing pediatric deaths with and without hospice supportDavid S Dickens
Journal of Palliative Medicine|July 15, 2009
Building competence in pediatric end-of-life careDavid S Dickens
Pediatric Blood & Cancer|April 25, 2017
Medication prior authorization in pediatric hematology and oncologyDavid S Dickens, Brad H Pollock
Pediatric Blood & Cancer|July 31, 2021
Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemiaTorin W Waters, David S Dickens
Psychology, Health & Medicine|November 3, 2021
Choice architecture for young adult blood donor recruitment - a feasibility studyJohn I Dickens, David S Dickens
Journal of Pediatric Hematology/Oncology|September 16, 2003
Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenograftsDavid S Dickens, Timothy P Cripe
Journal of Pediatric Hematology/Oncology|January 7, 2009
Therapeutic strategies for targeting mononuclear phagocytes in cancerDavid S Dickens, Paul T Jubinsky
Journal of Pediatric Hematology/Oncology|August 21, 2018
Barriers to Medication Access in Pediatric Oncology in the United StatesMichael J Kelly, Lillian Sung, David S Dickens
Journal of Pediatric Hematology/Oncology|September 19, 2008
New roles for mononuclear phagocytes in cancer biologyPaul T Jubinsky, David S Dickens, Mary K Short
JCO Oncology Practice|May 13, 2020
Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research ProgramsDavid S Dickens, Michael E Roth, Brad H Pollock, et al.
Pageof 4